Kubota Pharmaceutical Holdings Co (TSE:4596) Total Current Liabilities: 円187.82 Mil (As of Mar. 2026)


TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
45 GF Score
Price 円74.00
GF Value 円40.15
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Kubota Pharmaceutical Holdings Co Total Current Liabilities?

Kubota Pharmaceutical Holdings Co TSE:4596 +7.25% 45 Total Current Liabilities is 円187.82 Mil as of Mar. 2026. GuruFocus rates TSE:4596 with a GF Score™ of 45/100 and a GF Value™ of 円40.15 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Kubota Pharmaceutical Holdings Co's total current liabilities for the quarter that ended in Mar. 2026 was 円187.82

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Kubota Pharmaceutical Holdings Co Total Current Liabilities Related Terms

Kubota Pharmaceutical Holdings Co Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Kubota Pharmaceutical Holdings Co's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kubota Pharmaceutical Holdings Co Total Current Liabilities Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 542.35 360.83 282.91 151.26 157.37

Kubota Pharmaceutical Holdings Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.82 111.87 99.75 157.37 187.82
TSE:4596
45GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kubota Pharmaceutical Holdings Co Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Kubota Pharmaceutical Holdings Co's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=21.358+119.62
+Other Current Liabilities+Current Deferred Liabilities
=16.395+0
=157.37

Kubota Pharmaceutical Holdings Co's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=30.084+138.774
+Other Current Liabilities+Current Deferred Liabilities
=18.964+0
=187.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of 円187.82 Mil mean?
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Total Current Liabilities of 円187.82 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Kubota Pharmaceutical Holdings Co and its competitors.
Is Kubota Pharmaceutical Holdings Co's Total Current Liabilities too high?
Kubota Pharmaceutical Holdings Co's current Total Current Liabilities is 円187.82 Mil. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Total Current Liabilities compare to VRTX and REGN?
Kubota Pharmaceutical Holdings Co's Total Current Liabilities of 円187.82 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current Total Current Liabilities is 円187.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円40.15, compared to a current price of 円74.00 — trading 84.3% above its estimated fair value. The current Total Current Liabilities is 円187.82 Mil. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Total Current Liabilities is 円187.82 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円74.00 is trading 84.3% above its estimated GF Value™ of 円40.15. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • Total Current Liabilities: 円187.82 Mil
  • GF Value™: 円40.15 vs. price of 円74.00 (84.3% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
45GF Score

Get the complete analysis for TSE:4596

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円74.00
Price
円40.15
GF Value